Skip to main content
Veterinary Medicines

Cronyxin 50 mg/g Oral paste for horses

Authorised
  • Flunixin meglumine

Product identification

Medicine name:
Cronyxin 50 mg/g Oral paste for horses
Cronyxin, 50 mg/g suukaudne pasta hobustele
Active substance:
  • Flunixin meglumine
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        15
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • (ID5): 1 unspecified outer container with 12 Syringe (High Density PolyEthylene) with 33 gram(s) (396 gram(s))
  • (ID4): 1 unspecified outer container with 6 Syringe (High Density PolyEthylene) with 33 gram(s) (198 gram(s))
  • (ID3): 1 unspecified outer container with 3 Syringe (High Density PolyEthylene) with 33 gram(s) (99 gram(s))
  • (ID2): 1 unspecified outer container with 2 Syringe (High Density PolyEthylene) with 33 gram(s) (66 gram(s))
  • (ID1): 1 unspecified outer container with 1 Syringe (High Density PolyEthylene) with 33 gram(s) (33 gram(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bimeda Animal Health Limited
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2131
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0178/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 11/03/2022

Combined File of all Documents

English (PDF)
Published on: 19/12/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."